Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
622.00    4.00 (0.65%)
Bid:
621.00
Ask:
624.00
Spread: 3.00 (0.483%)
Market Cap: £904.33m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

AGM Trading Update

30 Jun 2026 07:00

RNS Number : 2531K
SAGA PLC
30 June 2026
 

30 June 2026

Saga plc

AGM Trading Update

Strong start to the new financial year, with trading in line with expectations

Ahead of its Annual General Meeting (AGM), Saga plc (Saga or the Group), the UK's specialist in products and services for people over 50, provides the following trading update covering the period from 1 February 2026 to 29 June 2026. The AGM will be held at 11.00am today at the offices of Herbert Smith Freehills Kramer, Exchange House, Primrose Street, London EC2A 2EG.

 

Group highlights

· The Group traded in line with expectations for the first four months of the year and remains on track to deliver its full year guidance.

· Travel continues to trade strongly, with Cruise performing ahead of expectations and a resilient customer base underpinning bookings in Holidays:

Ocean Cruise had a strong start to the year, with revenue for the first half expected to be ahead of the prior year, driven by 13% growth in booked per diems1 and a booked load factor1 of 93%. We have a high level of confidence when looking ahead to the full year and beyond, with customers typically booking well in advance, and commodity and foreign exchange risk now fully hedged to the end of 2027.

River Cruise also started the year well, with revenue for the first half of the year again expected to grow when compared with the prior year. Booked per diems1 are 4% higher than the prior year and the booked load factor1 is in line year-on-year, at 93%.

Holidays revenue and passenger numbers for the first half of the year are both expected to be ahead of the prior year. For the full year, based on current booking levels1, we expect revenue to be marginally ahead of the same point last year, albeit with passenger numbers potentially slightly behind and a higher proportion of short-haul holidays as a result of the conflict in the Middle East.

· Trading in Insurance Broking remains in line with expectations and the start of our long-term relationship with Ageas2 is progressing well:

New business, for both motor and home, is now live with Ageas2 and renewals are expected to follow later this year.

As a result of the strong performance under the motor and home partnership to date, we have triggered a contingent consideration payment of £10.5m from Ageas2, which we expect to receive in the coming days, following the outperformance of certain policy volume targets.

Private medical and travel insurance are also performing well, benefitting from increased focus and continued investment in marketing and pricing, with policies in force for the first half of the year expected to be materially higher than at 31 January 2026.

· Net Debt continues to reduce, standing at £464.7m3 at 31 May 2026, £104.8m lower than the £569.5m at 31 May 2025 and £34.8m lower than the £499.5m at the year end. This resulted in a Leverage Ratio of 3.2x, compared with 3.7x at the year end. Available Cash, also at 31 May 2026, was £186.5m3.

 

Mike Hazell, Group Chief Executive Officer, said:

"Saga has made a strong start to the year, building on the significant growth we achieved last year. Our momentum in Travel has continued, demonstrating the resilience of our customers and our diverse offering, despite the current geopolitical uncertainty. At this early stage of our partnership with Ageas2, we are already seeing encouraging signs to support our long-term growth ambitions, and the performance in our wider Insurance business continued to benefit from the more simplified and customer focussed operating model we now have.

"Looking ahead, we are focussed on continuing to grow our Travel businesses and completing the transition to our new Insurance model. We remain on track to deliver our full year guidance and continue to make clear progress towards our medium-term targets of at least £100.0m Underlying Profit Before Tax and a Leverage Ratio of below 2.0x by January 2030."

The Group's interim results for the six months ending 31 July 2026 will be announced on 30 September 2026.

For further information, please contact:

 

Saga plc

Emily Roalfe, Director of Investor Relations and Corporate Finance

Tel: 07732 093 007

Email: emily.roalfe@saga.co.uk

Headland Consultancy

Susanna Voyle

Will Smith

 

Tel: 07980 894 557

Tel: 07872 350 428

Tel: 020 3805 4822

Email: saga@headlandconsultancy.com

 

Notes to editors

Saga is a specialist in the provision of products and services for people over 50. The Saga brand is one of the most recognised and trusted brands in the UK. Saga is known for its high level of customer service and its high-quality, award-winning products and services including cruises and holidays, insurance, personal finance and publishing. www.saga.co.uk

 

1 Bookings at 28 June 2026

2 Wholly owned UK subsidiaries of Ageas SA/NV

3 While Net Debt has been adjusted to exclude £49.1m of upfront Ageas partnership proceeds that are expected to fund the working capital unwind, this remains included within Available Cash

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRGDLDDDDGLC
Date   Source Headline
25th Jun 20242:19 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Trading Update
12th Jun 20244:52 pmRNSDirector/PDMR Shareholding
5th Jun 20241:40 pmRNSHolding(s) in Company
5th Jun 20241:34 pmRNSDirector Declaration
29th May 20244:29 pmRNSDirector/PDMR Shareholding
21st May 20249:00 amRNSNotice of AGM
13th May 202410:08 amRNSRepayment of Bond
7th May 20244:32 pmRNSTotal Voting Rights
30th Apr 20249:15 amRNSIssue of Equity
17th Apr 20247:00 amRNSPreliminary Results
30th Jan 20247:00 amRNSTrading Update
26th Jan 20247:00 amRNSResponse to Media Coverage
15th Jan 20244:52 pmRNSHolding(s) in Company
21st Dec 20234:43 pmRNSHolding(s) in Company
21st Dec 20234:39 pmRNSDirector/PDMR Shareholding
21st Dec 20233:44 pmRNSDirectorate Change
8th Dec 202312:53 pmRNSHolding(s) in Company
28th Nov 20237:00 amRNSDirectorate Change
20th Nov 20234:00 pmRNSHolding(s) in Company
2nd Nov 20232:44 pmRNSDirector/PDMR Shareholding
17th Oct 202311:53 amRNSHolding(s) in Company
9th Oct 20237:00 amRNSDirectorate Change
27th Sep 20237:01 amRNSDirectorate Change
27th Sep 20237:00 amRNSInterim Results
9th Aug 20234:47 pmRNSDirector/PDMR Shareholding
9th Aug 20234:44 pmRNSTotal Voting Rights
1st Aug 20233:03 pmRNSIssue of Equity
26th Jul 20238:37 amRNSChange of Registered Office
22nd Jun 20232:38 pmRNSHolding(s) in Company
20th Jun 20233:53 pmRNSResults of 2023 Annual General Meeting
20th Jun 20237:00 amRNSAGM Trading Update
13th Jun 20235:00 pmRNSDirector/PDMR Shareholding
30th May 20232:19 pmRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSNotice of AGM
18th Apr 20237:00 amRNSAnnual Report and Accounts and Strategic Report
4th Apr 20237:00 amRNSPreliminary Results
2nd Mar 20239:10 amRNSTermination of discussions with Open Insurance
10th Feb 20237:00 amRNSResponse to Media Coverage
24th Jan 20237:01 amRNSCapital Markets Event
24th Jan 20237:00 amRNSTrading Update
23rd Jan 20237:00 amRNSResponse to Media Coverage
28th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20227:00 amRNSDirectorate Change
17th Nov 20222:47 pmRNSHolding(s) in Company
17th Nov 20229:00 amRNSEstablishment of New Committee
18th Oct 202210:15 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.